NATALIE DESANTIS: Open Payments
NPI 1669914453 · PORT CHARLOTTE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$697 in 27 payments from 11 companies in 2025. Trend: 2023 $248 · 2024 $2,708 · 2025 $697
Food & beverage: $629Education: $68
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $150 |
| Sumitomo Pharma America, Inc. | 6 | $145 |
| Astellas Pharma US Inc | 4 | $138 |
| Phathom Pharmaceuticals, Inc. | 1 | $80 |
| Lilly USA, LLC | 2 | $44 |
| Dexcom, Inc. | 1 | $32 |
| Exact Sciences Corporation | 1 | $29 |
| Abbott Laboratories | 1 | $23 |
| Esperion Therapeutics, Inc. | 1 | $20 |
| Acella Pharmaceuticals, LLC | 1 | $19 |
Products named: GEMTESA, Ozempic, VOQUEZNA, Veozah, MOUNJARO, Rybelsus, Dexcom G6 Transmitter, Cologuard Collection Kit.
Industry payments across FL — which companies pay providers there.
